Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Replication protein A2 pseudogene 1 (RPA2P1) is a non-functional DNA sequence that closely resembles the gene encoding Replication protein A2 (RPA2), a subunit of the replication protein A complex involved in DNA replication and repair[1][2]. As a pseudogene, RPA2P1 has lost the ability to produce a functional protein due to mutations or lack of essential regulatory elements[4]. There is no evidence for direct involvement in cellular pathways or diseases, nor is it used as a marker or therapeutic target. Like other pseudogenes, it may hypothetically participate in gene regulation (e.g., as miRNA decoys, sources of noncoding RNA, or gene conversion events), but there are no data indicating that RPA2P1 itself plays any such regulatory or pathogenic roles[4]. Key clarifications: - RPA2P1 is a *pseudogene*, not a therapeutically actionable target. - If you sought information about the functional protein (Replication protein A2), refer instead to "Replication protein A2 (RPA2)," which is involved in DNA replication and repair—a critical enzyme in genomic maintenance[1][2]. Summary: RPA2P1 (Replication protein A2 pseudogene 1) is not a functional target, not involved in therapeutic or pathological mechanisms, and not considered a receptor, enzyme, transporter, or similar class of molecule. Any interest in DNA replication or repair should be redirected to the functional gene *RPA2* and its protein product RPA2[1][2].
Not applicable; RPA2P1 does not act as a molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Replication protein A2 pseudogene 1 (RPA2P1).